News


Ubenwa - Learnings and Highlights from 2022

Ubenwa 2022: Year in Review

At Ubenwa, we are creating a future in which babies will be screened for medical issues using a simple recording of their cry. We are building a platform for sound-based medical diagnostics, starting with pediatric health. For the last 3 years, we have partnered with pediatricians across 3 continents to acquire large, diverse and unique clinical data ...
Ubenwa secures $2.5 million USD funding to help parents and clinicians understand an infant's cry

Ubenwa secures $2.5 million USD funding to help parents and clinicians understand an infant's cry

Backed by Radical Ventures and AI luminary Yoshua Bengio, Montreal company is partnering with leading children's hospitals to detect medical anomalies in baby cries
Ubenwa partners with top Neonatologist in Nigeria to validate tool for cry-based neurological screening in newborns

Ubenwa partners with top Neonatologist in Nigeria to validate tool for cry-based neurological screening in newborns

Ubenwa Health has launched today a new clinical study in collaboration with the Rivers State University Teaching Hospital in Port Harcourt, Nigeria. The new study is aimed at validating the capability of Ubenwa’s technology to rapidly identify the onset of neurological injury in neonates.
Review of 2019

Ubenwa — Highlights of 2020

When I discovered, six years ago, that we could screen for birth asphyxia using AI and the mic on a smartphone, I knew we had the potential of offering swift and reliable screening tools for one of the top 3 causes of newborn mortality today. Birth asphyxia yet causes over 2 million deaths and disabilities every year.
Review of 2019

Ubenwa Receives Social Entrepreneurship Awards

We are excited to announce that Ubenwa is one of only 35 ventures selected among over 2600 entrants to participate in the MIT Solve 2020-2021 social entrepreneurship program. As a Solver team in the Maternal and Newborn Health Challenge, we were awarded a grant of $10k USD.
Review of 2019

A Review of 2019

Ubenwa's journey of building clinically-backed, low-cost diagnostic tools for newborns is a long one! Last year we received ethics board approval to launch our clinical trial in Nigeria and Canada. We are now gathering the largest database of clinically-annotated infant cries with real patients. As we begin the new year, we would like to share some of the major milestones of 2019 and our plans for 2020.
WHO Top 30 Africa Health Innovators

WHO Top 30 Africa Health Innovators

Ubenwa Health was recognized by the World Health Organisation as one of top 30 healthcare innovators emerging from Africa.
A Review of 2018

A Review of 2018

At Ubenwa, we set for ourselves the task of addressing the problem of perinatal asphyxia - one of the top 3 causes of newborn mortality today. We are applying machine learning to detect this breathing deficiency using only the infant cry as input. This has enabled us to develop an extremely cost-effective tool - a smartphone app - that is accurate and fast. I encountered first-hand the problem of asphyxia during the years I spent volunteering with Enactus and Fisher Foundation in Nigeria. The journey to develop, test and clinically validate Ubenwa has been exciting but difficult most of the time, with many lessons learned. I would like to take the chance of a new year to look back, reflect on how far Ubenwa has come and take a peek at where we are headed.
Top 30 Teams in XPrize

Top 30 Teams in XPrize

Ubenwa is one of 30 teams that have qualified for the 3rd round of AI XPrize competition. [Update: The Ubenwa team voluntarily exited the AI XPrize as of June 6, 2019.]
TWiML Podcast

TWiML Podcast

This month, Ubenwa Founder Charles Onu gave a talk on the show - This Week in Machine Learning and AI (TWiML). You can listen here.
Pitches at Montreal AI Symposium and ITU Telecom World

Pitches at Montreal AI Symposium and ITU Telecom World

Charles presented Ubenwa at the Montreal AI Symposium. Watch here and Innocent pitched Ubenwa at ITU Telecom World in Busan, South Korea.